Loading clinical trials...
Loading clinical trials...
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - a Prospective Double-masked Cross-over Study
Conditions
Interventions
Cannabidiol Oral Solution [Epidiolex]
Locations
1
United States
Silkiss Eye Surgery
Oakland, California, United States
Start Date
May 20, 2020
Primary Completion Date
March 22, 2021
Completion Date
October 1, 2021
Last Updated
November 2, 2021
NCT01668186
NCT07069478
NCT06514911
NCT04680130
NCT07359976
NCT03938363
Lead Sponsor
Silkiss Eye Surgery
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions